HT’s National Facilities Invite Expressions of Interest for Large-Scale Genomics Projects
Human Technopole’s National Facilities are inviting Expressions of Interest (EoI) to access Whole Genome Sequencing and Analysis services for large-scale population genomics studies in the biomedical field.
Human Technopole’s National Facilities: New Call Following 147% Surge in Proposals
Human Technopole has opened a new Call for Access to its National Facilities on 1 February 2026, offering researchers from Italy the opportunity to access cutting-edge technologies and expertise across the institute’s advanced research platforms.
How sortilin senses thyroglobulin along its pathway to thyroid hormone release
Human Technopole researchers have identified the molecular mechanisms by which the membrane receptor sortilin binds thyroglobulin along its pathway to the release of thyroid hormones within the thyroid gland. The results of the research were published in Nature Communications and highlight that sortilin senses thyroglobulin via a short flexible “tag” which appears to be a common motif for the recognition of other partner proteins throughout our body.
AI4Life: A European Success for Artificial Intelligence in the Life Sciences
The AI4Life project, co-led by Florian Jug (Computational Biology Research Centre at Human Technopole) and Anna Kreshuk (EMBL), received the highest possible score in the European Commission’s final review, recognising its scientific impact and the quality of its achievements in applying artificial intelligence to biological image analysis.
Human Technopole awarded FIS grant for precision immunotherapy research
The Giustacchini Group of the Genomics Research Centre of Human Technopole has been awarded a €1.66 million grant from the Fondo Italiano per la Scienza (FIS 2) to advance precision immunotherapy for haematological malignancies. The three-year project, titled “Tailoring Precision Immunotherapy to Haematological Malignancies”, aims to develop more effective cell-based therapies for blood cancers by integrating molecular, cellular and systems-level analyses.
Previous page